CO2 Solutions Inc. has received a notice of allowance for an additional Danish Utility Model for its novel carbon capture process. The Quebec City-based firm received a similar notice last November.

"This is a second confirmation and additional clear validation of the robustness of our patent portfolio, and the uniqueness of our technology," said Evan Price, president and CEO at CO2 Solutions. "This second granted utility model adds additional depth to an already strong portfolio that, we believe, effectively covers the viable routes to commercialization of carbonic anhydrase enzyme-based systems for the capture of CO2. Our competitors should have no doubt that we will continue to defend our IP vigorously whenever and wherever necessary."

The company believes this utility model could have significant additional value relative to one or more CO2 capture projects currently underway in Denmark that the corporation believes may be infringing on the CO2 Solutions proprietary technology, including operations covered by this utility model.

Obtaining a positive decision on this second Danish utility model is all the more notable given that, once again, a leading European biotech company filed numerous documents and arguments against the pending CO2 Solutions application. Obtaining the allowance despite significant opposition further illustrates the strength and value of CO2 Solutions' intellectual property surrounding its innovative technologies. In addition, CO2 Solutions has numerous other patents/utility model pending in Denmark and Europe.